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SS21.
Mechanochemical Ablation (MOCA) of the Great Sa-
phenous Vein: Two-Year Results and Recommenda-
tions from the Initial Human Trial
Steve Elias. Columbia University and Medical Center,
Englewood, NJ
Objectives: The mechanochemical ablation catheter uti-
lizes a liquid sclerosant (sodium tetradecyl sulfate or aethox-
ysclerol) and a mechanical rotating wire to accomplish occlu-
sion of incompetent GSV or SSV. The procedure does not
require tumescence and is performed with local anesthesia at
the access site only. It can be characterized as mechanically
enhanced sclerotherapy performed in an office setting.
Methods: 30 GSVs in 29 patients underwent mi-
cropuncture access with local anesthesia only in this first in
man study.Through a5Fr.micropuncture sheath theMOCA
catheter was passed to a position 2 cms. from the saphe-
nofemoral junction. Catheter wire rotation was begun for 3
seconds at 3500 rpm. With the wire rotating, infusion of
sclerosant (1.5% sodium tetradecyl sulfate) and catheter pull-
back (1.5 mm./sec) was begun simultaneously. A total of 12
cc. of sclerosant was used for each GSV. The procedure
doesnot require the instillation of tumescent anesthesia.
Results: At 1 year 29 of 30GSVwere successfully treated.
Primaryclosure rate96.7%.At2years24patientswereexamined.
All 24 remain closed. No DVT, nerve or skin injury occurred.
Average total procedure time was 14 minutes. Catheter treat-
ment timewas 5minutes.TheMOCA technique has beenmod-
ified; lower volumes are nowused based on diameter and length
of vein treated. Catheter placement is closer to SFJ (1 cm.).
Conclusions: MOCA is as efficacious at 2 years as cur-
rent endothermal techniques without the need of tumescent
anesthesia and more effective than reported results of foam
sclerotherapy of theGSV. It is another alternativemodality for
most incompetent GSVs and SSVs.
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SS22.
See One, Sim One, Do One, Teach One: Results of a
Prospective Randomized Trial of Endovascular Skills
Training for Surgical Residents
Jason T. Lee, Amy Peruzzaro, Thomas Krummel, Ronald
L. Dalman. Division of Vascular Surgery, Stanford Univer-
sity Medical Center, Stanford, CA
Objectives: Surgical simulation has emerged as an impor-
tant adjunct to residency training in the era of duty-hour work
restrictions. We conducted a prospective randomized trial to
determinewhetheranendovascular simulation-basedcurriculum
improves the technical performance of surgical residents.
Methods: Third year residents rotating on vascular
surgery were randomized to SIMULATION consisting of
weekly faculty-mentored simulation-based sessions and
compared to CONTROL without simulation. Endovascu-
lar skills were assessed pre- and post-rotation on a high-
fidelity simulator utilizing a previously validated endovas-
cular global assessment scale (score 1-5), and a live OR
patient evaluation at the end of the rotation.
Results: From 2008-2011, 25 consecutive surgical resi-
dents (13 SIMULATION, 12 CONTROL) rotating on a uni-
versity VS service were enrolled. PRE-test assessment was not
differentbetweengroupsdocumenting similarbaseline skills (1.6
vs. 1.4), andoperative exposureduring their 8-week rotationwas
similar foropenandendovascular cases.Amountof time reading,
didactic teaching, and conference attendance was also similar
between cohorts. There was significant improvement on the
POST-test (3.6 vs. 1.5) assessed on the simulator for the entire
group, with the residents assigned to the SIMULATIONgroup
outperforming the CONTROL group (4.0 vs. 3.3) on the sim-
ulator and in the live patient OR assessment (3.5 vs. 2.5).
Conclusions: Implementation of an intensive simulation-
based endovascular curriculum during the VS rotationimproved
the technical skill of surgical residentsonahigh-fidelity simulator,
and translated to improved live OR performance beyond the
usual teaching obtained from standard clinical rotations.
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Outcomes Comparison of HeRO and Lower-Extremity
Arteriovenous Graft in Patients with Long-Standing
Renal Failure
Samuel N. Steerman, Jason Wagner, Jonathan A. Higgins,
Claudia Kim, Aleem Mirza, James Pavela, Jean M. Pan-
neton, Marc Glickman. Eastern Virginia Medical School,
Norfolk, VA
Objectives: The HeRO (Hemodialysis Reliable Out-
flow) graft is becoming a recognized alternative to
Lower Extremity AV Grafts (LEAVG) as an option for
patients who have exhausted traditional upper extremity
access; however it is unclear which should be applied
preferentially.
Methods: A retrospective review of LEAVG and
HeRO implants from January 2006 to August 2010 was
performed. Patient demographics, medical history, proce-
dural data and outcomes were evaluated.
Results: Within the time periods, 62 HeRO’s were
placed in 61 patients and 23 LEAVG were placed in 21
patients. Demographics were similar between the two
groups for gender, age, BMI, and race. Average fol-
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low-up was 14.6 months. The HeRO patients under-
went a mean of 6.4 previous TDCs and 3.1 previous
AVG/AVFs. The LEAVG patients underwent a mean of
4.1 previous TDCs and 2.8 previous AVG/AVFs. The
principal difference was a 1 year primary patency of 26%
for the HeRO group and 60% for the LEAVG group
(P  .01). The number of interventions to maintain
patency was 6.2 per year in the HeRO group and 3.7 per
year in the AVG group (P  .40). Secondary patency at
1 year was 61% for the HeRO patients and 66% for the
AVG patients (P  .56). The HeRO group and LEAVG
had no difference in infection rate (31% vs. 30%) or
mortality rate (33% vs 21% respectively) at 1 year.
Conclusions: In access challenged patients, LEAVG
and HeRO offer a higher incidence of infection, mortality
and loss of patency compared to traditional upper extremity
access. The LEAVG offers improved primary patency rate
over the HeRO device.
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Video Presentation
Percutaneous Thrombectomy of a Dialysis Graft in the
Office Setting
Krishna Jain1, John Munn2, Mark Rummel2, Dan John-
ston2, Chris Longton2. 1Advanced Vacular Surgery, Kala-
mazoo, MI; 2Advanced Vascular Surgery, Kalamazoo, MI
Background: With the advent of endovascular techniques
thrombectomy of occluded dialysis graft can be carried out per-
cutaneously. Over the last few years various devices have been
approved for mechanical thrombectomy of dialysis graft. We
describe a technique thatwehave developedwithout using these
devices, in our office based endovascular suite.
Technical Description: Patient is given hydrocodone 5
mg, Diazepam 5 mg and Cefazolin 500 mg orally before the
procedure. Patient is not fasting. After prepping and draping
the extremity Xylocaine 1% is infiltrated in the skin. Crossing
micro puncture needles are introduced into the graft pointing
towards each anastomosis. Guide wires are threaded through
the needles. Needles are removed andmicro puncture sheaths
are threaded over the guide wires. Fistulogram is done to
confirm the thrombosis and to make sure the catheters are in
the lumen. Two ml of tissue plasminogen activator is intro-
duced through each catheter. After 15minutes glide wires are
threaded through each sheath and these are switched to 6
French sheaths. The glidewires should cross both anastomo-
ses. Five French embolectomy catheter is threaded over the
arterial wire and clot is pulled out of the arterial side and
flushed out of the side port of the sheath. Same procedure is
carried out on venous side. Fistulogram is performed and the
procedure is repeated until there is no residual clot. Invariably
there is stenosis present at the graft vein anastomosis or in the
graft circuit. Rarely there is arterial stenosis. If it is a 6mm graft
8mmballoon is used todilate the area of stenosis at the graft vein
anastomosis. The sheaths and guide wires are removed and
puncture sites are closedwith nylon suture. the graft can be used
immediately. A similar procedure can be used for a fistula.
Author Disclosures: K. Jain: Nothing to disclose; D.
Johnston: Nothing to disclose; C. Longton: Nothing to
disclose; J. Munn: Nothing to disclose; M. Rummel:
Nothing to disclose.
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Hemodialysis A and Age-Related Postoperative Out-
comes: Which Fistula First?
Steven Abramowitz, Angela A. Kokkosis, Jonathan Schwit-
zer, Harry Schanzer, Victoria Teodorescu. Mount Sinai
Medical Center, New York, NY
Objectives: The National Kidney Foundation recom-
mends the preferential creation of radiocephalic fistulas
(RCF) over that of brachiocephalic fistulas (BCF) for he-
modialysis access. This study tested the hypothesis that
RCF creation in patients greater than 68 years of age may
result in a more postoperative complications.
Methods:A total of 287patients older than68 years of age
with preoperative vein mapping and regular follow up after cre-
ation of arteriovenous fistula constituted this retrospective study.
Within this group, 164 patients underwent RCF creation and
123underwentBCFcreation.Medical recordswere analyzed for
thenumberof central venous catheter days, thenumberof fistula
related procedures recorded and the number of access related
hospitalizations for each patient. Bivariate analysis using linear
modeling and one-way analysis of variance was used to assess
cohort differences.
Results: Among patients who underwent creation of
BCF, the average number of central venous catheter days was
53.3 days per patient, the average number of fistula related
Fig.
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